Holen Sie sich die Stockscreener-App
0.0419
26.93%
0.0096
Schlusskurs vom Vortag:
$0.0323
Offen:
$0.0285
24-Stunden-Volumen:
175.35M
Relative Volume:
12.70
Marktkapitalisierung:
$3.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-88.35M
KGV:
-0.0313
EPS:
-1.3391
Netto-Cashflow:
$-81.07M
1W Leistung:
-76.22%
1M Leistung:
-86.36%
6M Leistung:
-91.49%
1J Leistung:
-95.83%
1-Tages-Spanne:
$0.0277
$0.055
1-Wochen-Bereich:
$0.0277
$0.06
52-Wochen-Spanne:
$0.0277
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Firmenname
Io Biotech Inc
Sektor
Branche
Telefon
(457) 070-2980
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.0429 | 2.32M | 0 | -88.35M | -81.07M | -1.3391 |
VRTX
Vertex Pharmaceuticals Inc
|
433.53 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.48 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.68 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.95 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.57 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2026-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | Herabstufung | TD Cowen | Buy → Hold |
Io Biotech Inc Aktie (IOBT) Neueste Nachrichten
IOBT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why are shares of IO Biotech plummeting? - MSN
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy - Benzinga
Layoff Tracker: Gilead Lays Off Employees at California Headquarters - BioSpace
The rollercoaster ride stopps and danish IO Biotech goes bust - European Biotechnology Magazine
Earnings Beat: What is the long term forecast for IO Biotech Inc stockQuarterly Market Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
IOBT SEC FilingsIo Biotech, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
IO Biotech, Inc. Files Form 8-K With SEC – Company Information, Stock Details, and Regulatory Compliance (March 31, 2026) - Minichart
Cancer Vaccine Developer Files Ch. 7 After Trials Fall Short - Law360
IO Biotech Files Chapter 7, Ceases Operations, Liquidates - TipRanks
Why Are Shares Of IO Biotech Plummeting? - Benzinga
Io Biotech Incfiles voluntary chapter 7 bankruptcy petition on March 31, 2026SEC filing - MarketScreener
IO Biotech (IOBT) shuts down and files for Chapter 7 liquidation - Stock Titan
Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech
Aug Swings: Will IO Biotech Inc outperform its industry peersRisk Management & Stepwise Swing Trade Plans - baoquankhu1.vn
Big Money Moves: Will IO Biotech Inc outperform tech stocksExit Point & Short-Term Trading Alerts - baoquankhu1.vn
Insider Trends: Whats the outlook for Samfine Creation Holdings Group Limiteds sectorTrade Risk Assessment & AI Forecasted Stock Moves - baoquankhu1.vn
IO Biotech (IOBT) to Release Quarterly Earnings on Monday - Defense World
Is Haverty Furniture Companies Inc part of any major index2026 PostEarnings & Real-Time Volume Triggers - baoquankhu1.vn
Here's why IO Biotech, Inc. (IOBT) looks ripe for bottom fishing - MSN
IOBT Stock Price and Chart — NASDAQ:IOBT - TradingView
IOBT Earnings History & Surprises | EPS & Revenue Results | IO BIOTECH INC (NASDAQ:IOBT) - ChartMill
Market Overview: Is IO Biotech Inc stock a smart retirement pickEarnings Performance Report & Smart Swing Trading Techniques - baoquankhu1.vn
IO Biotech, Inc. (NASDAQ:IOBT) Sees Large Decline in Short Interest - Defense World
IOBT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IOBT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Portfolio Update: Is IO Biotech Inc stock a smart retirement pick2025 Support & Resistance & Consistent Profit Trading Strategies - baoquankhu1.vn
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
Is IO Biotech Inc. stock attractive for ETFs2025 Earnings Surprises & Low Risk Entry Point Tips - mfd.ru
Cancer Vaccines Competitive Landscape Report 2026: Comprehensive Insights About 250+ Companies and 300+ DrugsCollaborations and Licensing by Key Players Like Moderna, Merck, and IO Biotech - Yahoo Finance
Will IO Biotech Inc. outperform its industry peers2025 Key Lessons & Verified Chart Pattern Signals - mfd.ru
Chart Watch: Will IO Biotech Inc outperform tech stocksBuy Signal & Fast Exit Strategy with Risk Control - baoquankhu1.vn
IOBT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
IOBT PE Ratio & Valuation, Is IOBT Overvalued - Intellectia AI
IO Biotech Faces Nasdaq Noncompliance, Potential Delisting Risk - The Globe and Mail
IO Biotech Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns IO Biotech (NASDAQ: IOBT) on $50M market value rule - Stock Titan
Here's Why IO Biotech, Inc. (IOBT) Looks Ripe for Bottom Fishing - Finviz
Is IO Biotech Inc. a top pick in the sectorJuly 2025 Catalysts & Short-Term High Return Ideas - mfd.ru
Guidance Update: Is IO Biotech Inc in a consolidation phaseJuly 2025 PostEarnings & Safe Capital Growth Tips - baoquankhu1.vn
Point72 discloses 5.6% IO Biotech (IOBT) ownership stake - Stock Titan
IO Biotech Provides Corporate Update - marketscreener.com
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IO Biotech (IOBT) launches restructuring, CMO exit and up to $2.6M charges - Stock Titan
IO Biotech hires Raymond James as advisor, cuts workforce By Investing.com - Investing.com Canada
IO Biotech Engages Raymond James as Financial Advisor Amid Workforce Reduction and Cost-Containment Measures - Quiver Quantitative
Cancer vaccine maker IO Biotech cuts staff, hires Raymond James - Stock Titan
Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com South Africa
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):